Input CIK:

Show Other Options & Instructions

Owned(%):
Shares Outstanding(‱):
Transaction Code:

Instructions

Month Back: Display transaction record of previous n months.

Owned(%): Transaction shares relative to shares owned.

Shares Outstanding(‱): Transaction shares relative to shares outstanding.

Check Insider Trading (Reporter) for more details.

GAROFALO ELIZABETH A. 1826361 Data last updated 2024-05-14 07:02:16 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.

3M 6M 1Y 2Y MAX

Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-06-05 2022-06-07 2022-06-07 to 2023-06-01 4 Garofalo Elizabeth A. DIRECTOR acq 16862.0 89.79 1.04 0.0 Direct Common Stock ACADIA PHARMACEUTICALS INC

code_M

code  M 		18780.0 thumbnail 162.63 (ACAD)
2023-06-15 2023-06-14 2023-06-14 4 Garofalo Elizabeth A. DIRECTOR acq 26250.0 73.51 3.15 0.0 Direct Common Stock ALECTOR, INC.

code_A

code  A 		35709.0 83.35 (ALEC)
2023-11-28 2023-11-24 2023-11-24 4 Garofalo Elizabeth A. DIRECTOR dsp 2918.0 15.54 0.18 0.0 Direct Common Stock ACADIA PHARMACEUTICALS INC

code_G

code  G 		15862.0 164.18 (ACAD)
2023-12-06 2023-12-05 2023-12-05 4 Garofalo Elizabeth A. DIRECTOR dsp 9459.0 26.49 1.12 0.0 Direct Common Stock ALECTOR, INC.

code_G

code  G 		26250.0 84.14 (ALEC)
2024-03-11 2024-03-08 2024-03-08 4 Garofalo Elizabeth A. DIRECTOR acq 3500.0 100.0 0.53 18.56 Direct Common Shares XENON PHARMACEUTICALS INC.

code_M

code  M 		3500.0 65.43 (XENE)
2024-03-11 2024-03-08 2024-03-08 4 Garofalo Elizabeth A. DIRECTOR dsp 3500.0 100.0 0.53 45.88 Direct Common Shares XENON PHARMACEUTICALS INC.

code_F,S

code  F  S 		0.0 thumbnail 65.43 (XENE)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-06-02 2023-06-02 2023-06-02 4 Garofalo Elizabeth A. DIRECTOR acq 18475.0 100.0 2.91 38.96 Direct Stock Option (Right To Buy) XENON PHARMACEUTICALS INC.

code_A

code  A 		18475.0 63.56 (XENE)
2023-06-05 2022-06-07 2023-06-01 4 Garofalo Elizabeth A. DIRECTOR acq 6652.0 100.0 0.41 0.0 Direct Restricted Stock Units ACADIA PHARMACEUTICALS INC

code_A

code  A 		6652.0 162.63 (ACAD)
2023-06-05 2022-06-07 2022-06-07 to 2023-06-01 4 Garofalo Elizabeth A. DIRECTOR dsp 16862.0 100.0 1.04 0.0 Direct Restricted Stock Units ACADIA PHARMACEUTICALS INC

code_M

code  M 		0.0 thumbnail 162.63 (ACAD)
2023-06-05 2022-06-07 2023-06-01 4 Garofalo Elizabeth A. DIRECTOR acq 11045.0 100.0 0.68 23.9 Direct Director Stock Options (Right To Buy) ACADIA PHARMACEUTICALS INC

code_A

code  A 		11045.0 162.63 (ACAD)
2023-06-15 2023-06-14 2023-06-14 4 Garofalo Elizabeth A. DIRECTOR acq 12360.0 100.0 1.48 7.71 Direct Stock Option (Right To Buy) ALECTOR, INC.

code_A

code  A 		12360.0 83.35 (ALEC)
2024-03-11 2024-03-08 2024-03-08 4 Garofalo Elizabeth A. DIRECTOR dsp 3500.0 17.5 0.53 18.56 Direct Stock Option (Right To Buy) XENON PHARMACEUTICALS INC.

code_M

code  M 		16500.0 65.43 (XENE)

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)